600771 广誉远
已收盘 06-05 15:00:00
资讯
新帖
简况
广誉远：关于使用公积金弥补亏损的议案
证券之星 · 17:00
广誉远：关于使用公积金弥补亏损的议案
广誉远：公司主营业务为核心经典名方中成药产品的生产与销售
证券之星 · 17:00
广誉远：公司主营业务为核心经典名方中成药产品的生产与销售
广誉远：持续优化各品类产品的宣传
证券之星 · 17:00
广誉远：持续优化各品类产品的宣传
广誉远：本次股份回购已完成，计划用于员工持股计划或股权激励
证券之星 · 06-03 16:36
广誉远：本次股份回购已完成，计划用于员工持股计划或股权激励
广誉远：以提质增效为核心，聚焦主业深耕细作
证券之星 · 06-03 16:36
广誉远：以提质增效为核心，聚焦主业深耕细作
广誉远：公司会结合自身经营战略审慎研判
证券之星 · 06-03 16:27
广誉远：公司会结合自身经营战略审慎研判
广誉远：持续依托非遗及文旅资源常态化输出品牌内容
证券之星 · 06-03 16:27
广誉远：持续依托非遗及文旅资源常态化输出品牌内容
广誉远：线下精品门店提供中医诊疗、针灸推拿、健康管理等多项服务
证券之星 · 06-03 16:27
广誉远：线下精品门店提供中医诊疗、针灸推拿、健康管理等多项服务
广誉远（600771）披露股份回购实施结果暨股份变动公告，6月1日股价下跌0.92%
证券之星 · 06-01
广誉远（600771）披露股份回购实施结果暨股份变动公告，6月1日股价下跌0.92%
广誉远：公司各类产品定价均综合考量原料生产成本、传统炮制工艺价值、品牌长远发展规划及行业竞争态势
证券之星 · 06-01
广誉远：公司各类产品定价均综合考量原料生产成本、传统炮制工艺价值、品牌长远发展规划及行业竞争态势
广誉远：公司高管平均薪酬非省属企业第一梯队
证券之星 · 06-01
广誉远：公司高管平均薪酬非省属企业第一梯队
广誉远：正和岛调研有助于架起高端企业家社群与中医药文化的桥梁纽带
证券之星 · 06-01
广誉远：正和岛调研有助于架起高端企业家社群与中医药文化的桥梁纽带
广誉远（600771）披露将参加山西辖区上市公司2026年投资者网上集体接待日暨年报业绩说明会，5月15日股价下跌1.05%
证券之星 · 05-15
广誉远（600771）披露将参加山西辖区上市公司2026年投资者网上集体接待日暨年报业绩说明会，5月15日股价下跌1.05%
广誉远（600771）披露重大诉讼进展公告，5月14日股价上涨0.81%
证券之星 · 05-14
广誉远（600771）披露重大诉讼进展公告，5月14日股价上涨0.81%
每周股票复盘：广誉远（600771）累计回购211.56万股耗资3637万元
证券之星 · 05-10
每周股票复盘：广誉远（600771）累计回购211.56万股耗资3637万元
广誉远：累计回购公司股份2115600股
证券日报 · 05-06
广誉远：累计回购公司股份2115600股
每周股票复盘：广誉远（600771）一季报营收增17.04%
证券之星 · 04-26
每周股票复盘：广誉远（600771）一季报营收增17.04%
广誉远（600771）2026年一季报简析：营收净利润同比双双增长
证券之星 · 04-24
广誉远（600771）2026年一季报简析：营收净利润同比双双增长
图解广誉远一季报：第一季度单季净利润同比增长4.96%
证券之星 · 04-23
图解广誉远一季报：第一季度单季净利润同比增长4.96%
广誉远(600771.SH)发布一季度业绩，归母净利润6674万元，同比增长4.96%
智通财经 · 04-22
广誉远(600771.SH)发布一季度业绩，归母净利润6674万元，同比增长4.96%
加载更多
公司概况
公司名称：
广誉远中药股份有限公司
所属行业：
医药制造业
上市日期：
1996-11-05
主营业务：
广誉远中药股份有限公司的主营业务是中药产品的生产与销售。公司的主要产品是龟龄集、定坤丹大蜜丸、定坤丹水蜜丸、定坤丹口服液、安宫牛黄丸、牛黄清心丸、加味龟龄集酒、远字牌龟龄集酒。公司产品先后获得“山西精品”认定，六味地黄丸传统制作技艺及姜炭制作技艺入选晋中市非物质文化遗产名录。
发行价格：
4.80
{"stockData":{"symbol":"600771","market":"SH","secType":"STK","nameCN":"广誉远","latestPrice":14.57,"timestamp":1780642801000,"preClose":14.8,"halted":0,"volume":6203200,"delay":0,"changeRate":-0.0155,"floatShares":488999999,"shares":488999999,"eps":0.1353,"marketStatus":"已收盘","change":-0.23,"latestTime":"06-05 15:00:00","open":14.74,"high":14.91,"low":14.56,"amount":90991400,"amplitude":0.0236,"askPrice":14.57,"askSize":55,"bidPrice":14.56,"bidSize":525,"shortable":0,"etf":0,"ttmEps":0.1353,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780882200000},"marketStatusCode":5,"adr":0,"adjPreClose":14.8,"symbolType":"stock","openAndCloseTimeList":[[1780623000000,1780630200000],[1780635600000,1780642800000]],"highLimit":16.28,"lowLimit":13.32,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":489491141,"isCdr":false,"pbRate":4.2,"roa":"--","peRate":107.686622,"roe":"4.01%","epsLYR":0.13,"committee":0.007856,"marketValue":7132000000,"turnoverRate":0.0127,"status":1,"floatMarketCap":7132000000},"requestUrl":"/m/hq/s/600771","defaultTab":"news","newsList":[{"id":"2641116760","title":"广誉远：关于使用公积金弥补亏损的议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2641116760","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641116760?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:00","pubTimestamp":1780650047,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远06月05日在投资者关系平台上答复投资者关心的问题。根据《公司法》《公司章程》及《股东会议事规则》等相关规定，公司2025年度股东会将在上一会计年度结束后的六个月内举行，《关于使用公积金弥补亏损的议案》尚需提交该次股东会审议，公司将严格按规定于会议召开20日前发布会议通知，请您关注后续公告。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028932.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","600771","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641116734","title":"广誉远：公司主营业务为核心经典名方中成药产品的生产与销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2641116734","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641116734?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:00","pubTimestamp":1780650045,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远06月05日在投资者关系平台上答复投资者关心的问题。公司时刻关注二级市场股价波动情况，高度重视市值管理相关工作的开展落地与保障全体股东的合法权益。公司主营业务为核心经典名方中成药产品的生产与销售，将继续聚焦主责主业开展相关工作，您的建言与公司战略匹配度不高，公司暂不考虑，如涉及资产重组等相关资本运作事项，公司会严格按照相关规定履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","600771","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641162041","title":"广誉远：持续优化各品类产品的宣传","url":"https://stock-news.laohu8.com/highlight/detail?id=2641162041","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641162041?lang=zh_cn&edition=full","pubTime":"2026-06-05 17:00","pubTimestamp":1780650042,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远06月05日在投资者关系平台上答复投资者关心的问题。一切有利于公司发展、产品拓量的事项，公司均会结合相关法律法规要求及自身发展情况审慎研判，持续优化各品类产品的宣传，进一步深挖养生酒的品牌赋能价值，相关信息已反馈，具体情况请以公司实际落地举措为准。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0077","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640818977","title":"广誉远：本次股份回购已完成，计划用于员工持股计划或股权激励","url":"https://stock-news.laohu8.com/highlight/detail?id=2640818977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640818977?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:36","pubTimestamp":1780475788,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远06月03日在投资者关系平台上答复投资者关心的问题。后续公司若存在相关需公开披露事项，将结合实际依规制定方案，及时履行披露义务。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300033437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0188","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640397781","title":"广誉远：以提质增效为核心，聚焦主业深耕细作","url":"https://stock-news.laohu8.com/highlight/detail?id=2640397781","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640397781?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:36","pubTimestamp":1780475787,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远06月03日在投资者关系平台上答复投资者关心的问题。当前管理层正以提质增效为核心，聚焦主业深耕细作，持续优化运营管理、强化费用管控、加快核心产品市场突破，全力以赴提升经营质量与业绩表现，以扎实的经营成果切实回报全体投资者，请您谨慎判断，理性决策，注意投资风险。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300033435.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","600771","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640972033","title":"广誉远：公司会结合自身经营战略审慎研判","url":"https://stock-news.laohu8.com/highlight/detail?id=2640972033","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640972033?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:27","pubTimestamp":1780475260,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远(600771)06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘：作为股东，建议尽快引入酒水产业资本赋能龟龄集酒，机会稍纵即逝。借助产业资本资源，既能扩充产能、拓展全国渠道，也能助力品牌升级、放大非遗与老字号价值，推动酒板块做大做强。请问公司目前是否有引进产业资本的相关规划？若有，能否告知大致落地时间表？广誉远回复：您好，感谢您的关注及建议。公司十分重视龟龄集酒业务发展，对于引入酒水产业资本一事，公司会结合自身经营战略审慎研判，后续若开展相关事项，公司将依规及时披露。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300033197.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0188","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640972032","title":"广誉远：持续依托非遗及文旅资源常态化输出品牌内容","url":"https://stock-news.laohu8.com/highlight/detail?id=2640972032","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640972032?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:27","pubTimestamp":1780475259,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远06月03日在投资者关系平台上答复投资者关心的问题。公司品牌传播工作始终围绕“广誉远国药，养生精品药”的品牌定位推进实施。公司将持续依托非遗及文旅资源常态化输出品牌内容，在合规范围内持续让博物馆和非遗资源赋能企业价值，循序渐进拓宽多样化媒体传播路径、持续做大品牌声量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300033196.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600771","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640972215","title":"广誉远：线下精品门店提供中医诊疗、针灸推拿、健康管理等多项服务","url":"https://stock-news.laohu8.com/highlight/detail?id=2640972215","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640972215?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:27","pubTimestamp":1780475254,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远06月03日在投资者关系平台上答复投资者关心的问题。公司线下精品门店依托国药堂、国医馆、博物馆等开展相关营销工作，既销售产品，也提供中医诊疗、针灸推拿、健康管理等多项服务，同时提供中医药场景沉浸式体验和展示非遗文化的博物馆，以场景化服务带动产品销售，持续提升终端运营质量与单店效能。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300033191.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","600771","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640950672","title":"广誉远（600771）披露股份回购实施结果暨股份变动公告，6月1日股价下跌0.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640950672","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640950672?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:26","pubTimestamp":1780323982,"startTime":"0","endTime":"0","summary":"近日，广誉远中药股份有限公司发布《关于股份回购实施结果暨股份变动的公告》。公告显示，公司于2026年3月26日披露股份回购方案，拟以集中竞价交易方式回购股份，用于员工持股计划或股权激励，回购金额为3,000万元至5,000万元，价格上限为26.09元/股，实施期限为2026年3月27日至9月26日。回购股份已存放于回购专用证券账户，后续将用于员工持股计划或股权激励。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100041118.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0188","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640932038","title":"广誉远：公司各类产品定价均综合考量原料生产成本、传统炮制工艺价值、品牌长远发展规划及行业竞争态势","url":"https://stock-news.laohu8.com/highlight/detail?id=2640932038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640932038?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:51","pubTimestamp":1780303903,"startTime":"0","endTime":"0","summary":"公司各类产品定价并没有所谓延续前大股东定价体系之说，现行价格均综合考量原料生产成本、传统炮制工艺价值、品牌长远发展规划及行业竞争态势，经过系统化综合研判后审慎确定。其次，市场中将定坤丹口服液与同类滋补产品简单对标、单纯比价并不客观，二者组方配伍、药材选材均存在较大差异，生产成本天然有所区别。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100024922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","BK0077","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640193273","title":"广誉远：公司高管平均薪酬非省属企业第一梯队","url":"https://stock-news.laohu8.com/highlight/detail?id=2640193273","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640193273?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:51","pubTimestamp":1780303896,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远(600771)06月01日在投资者关系平台上答复投资者关心的问题。投资者提问：柳花兰年薪62.8万最高，吕洪宇60万，王锋27.4万最低。请问广誉远高管平均薪酬是不是省属企业第一梯队？柳花兰年薪是王锋年薪2.3倍，是什么原因造成的？谢谢。广誉远回复：您好，感谢您的关注。公司高管平均薪酬非省属企业第一梯队。公司董事、高管薪酬因职务、专业胜任能力、履历背景、承担职责的价值贡献差异而有所不同。柳花兰为上市公司资深副总裁，王锋为本届董事会新晋职工代表董事。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100024918.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0077","600771","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640932688","title":"广誉远：正和岛调研有助于架起高端企业家社群与中医药文化的桥梁纽带","url":"https://stock-news.laohu8.com/highlight/detail?id=2640932688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640932688?lang=zh_cn&edition=full","pubTime":"2026-06-01 16:39","pubTimestamp":1780303166,"startTime":"0","endTime":"0","summary":"正和岛作为国内顶尖的企业家社群，此次莅临公司调研，是双方基于价值共识的深度认同。双方的交流，有助于架起高端企业家社群与中医药文化的桥梁纽带，将广誉远近500年无断代传承的品牌文化与龟龄集、定坤丹等核心产品的独特价值，精准触达主流商业决策圈层，在增强文化共识和品牌认同的同时，帮助公司高品质产品为社会精英人群提供更好的服务，拓宽养生精品中药消费场景，为公司长远发展蓄能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100024560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0188","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635955033","title":"广誉远（600771）披露将参加山西辖区上市公司2026年投资者网上集体接待日暨年报业绩说明会，5月15日股价下跌1.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635955033","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635955033?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:30","pubTimestamp":1778855443,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，广誉远报收于16.05元，较前一交易日下跌1.05%，最新总市值为78.56亿元。该股当日开盘16.38元，最高16.43元，最低15.94元，成交额达1.11亿元，换手率为1.4%。近日，广誉远中药股份有限公司发布《关于参加山西辖区上市公司2026年投资者网上集体接待日暨年报业绩说明会活动的公告》。公司高管将就2025年度业绩、公司治理、发展战略、经营状况等与投资者交流。投资者可提前通过电话、邮件等方式反馈关注问题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500044235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0077","BK0188","600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635774578","title":"广誉远（600771）披露重大诉讼进展公告，5月14日股价上涨0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635774578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635774578?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:30","pubTimestamp":1778769034,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，广誉远报收于16.22元，较前一交易日上涨0.81%，最新总市值为79.4亿元。该股当日开盘16.12元，最高16.29元，最低15.84元，成交额达1.62亿元，换手率为2.06%。近日，广誉远中药股份有限公司发布《关于重大诉讼的进展公告》。公告显示，公司作为原告，因业绩承诺补偿合同纠纷起诉西安东盛集团有限公司，陕西省西安市中级人民法院已作出一审判决。目前处于上诉期内，判决尚未生效。公司还披露了新增5项未决诉讼事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400043105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771","BK0239","BK0188","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634144974","title":"每周股票复盘：广誉远（600771）累计回购211.56万股耗资3637万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2634144974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634144974?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:44","pubTimestamp":1778352253,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，广誉远报收于16.54元，较上周的16.76元下跌1.31%。本周，广誉远5月6日盘中最高价报16.92元。本周关注点来自公司公告汇总：广誉远累计回购股份2,115,600股，占公司总股本的0.43%。公司公告汇总广誉远中药股份有限公司于2026年3月26日审议通过回购股份方案，回购期限为2026年3月27日至9月26日，预计回购金额3,000万元至5,000万元，用途为员工持股计划或股权激励。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001002.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","600771","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633397931","title":"广誉远：累计回购公司股份2115600股","url":"https://stock-news.laohu8.com/highlight/detail?id=2633397931","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633397931?lang=zh_cn&edition=full","pubTime":"2026-05-06 20:59","pubTimestamp":1778072340,"startTime":"0","endTime":"0","summary":"证券日报网讯 5月6日，广誉远（维权）发布公告称，公司于2026年4月通过集中竞价交易方式已累计回购公司股份2，115，600股，占公司总股本比例为0.43%，购买的最高价为17.57元/股、最低价为16.68元/股，支付的金额为36，374，396.66元（不含交易费用）。截至2026年4月30日，公司已累计回购股份2，115，600股，占公司总股本比例为0.43%，支付的金额为36，374，396.66元。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-06/doc-inhwyqfw8148519.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-06/doc-inhwyqfw8148519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600771","BK0077","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630804505","title":"每周股票复盘：广誉远（600771）一季报营收增17.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630804505","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630804505?lang=zh_cn&edition=full","pubTime":"2026-04-26 03:37","pubTimestamp":1777145830,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，广誉远报收于17.05元，较上周的17.35元下跌1.73%。本周关注点来自业绩披露要点：广誉远2026年一季报主营收入4.88亿元，同比上升17.04%。股本股东变化股东户数变动截至2026年3月31日，广誉远股东户数为6.59万户，较2025年12月31日增加1419.0户，增幅2.2%。广誉远中药股份有限公司关于未弥补亏损超过实收股本总额三分之一的公告截至2025年12月31日，公司合并报表未弥补亏损为47,117.78万元，实收股本为48,949.11万元，未弥补亏损超过实收股本总额三分之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629847722","title":"广誉远（600771）2026年一季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2629847722","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629847722?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:12","pubTimestamp":1777039941,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期广誉远发布2026年一季报。根据财报显示，广誉远营收净利润同比双双增长。截至本报告期末，公司营业总收入4.88亿元，同比上升17.04%，归母净利润6673.81万元，同比上升4.96%。本次财报公布的各项数据指标表现尚佳。去年的净利率为4.65%，算上全部成本后，公司产品或服务的附加值不高。生意拆解：公司过去三年净经营资产收益率分别为6.7%/5.6%/5.5%，净经营利润分别为9285.12万/8360.09万/6368.96万元，净经营资产分别为13.79亿/14.91亿/11.6亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400064674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629402167","title":"图解广誉远一季报：第一季度单季净利润同比增长4.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629402167","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629402167?lang=zh_cn&edition=full","pubTime":"2026-04-23 01:52","pubTimestamp":1776880350,"startTime":"0","endTime":"0","summary":"证券之星消息，广誉远2026年一季报显示，一季度公司主营收入4.88亿元，同比上升17.04%；归母净利润6673.81万元，同比上升4.96%；扣非净利润6653.99万元，同比上升4.55%；负债率32.34%，投资收益-9.35万元，财务费用39.71万元，毛利率67.89%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300003705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600771"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629404661","title":"广誉远(600771.SH)发布一季度业绩，归母净利润6674万元，同比增长4.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629404661","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629404661?lang=zh_cn&edition=full","pubTime":"2026-04-22 20:07","pubTimestamp":1776859634,"startTime":"0","endTime":"0","summary":"智通财经APP讯，广誉远(600771.SH)披露2026年第一季度报告，报告期公司实现营收4.88亿元，同比增长17.04%;归母净利润6674万元，同比增长4.96%;扣非净利润6654万元，同比增长4.55%。基本每股收益0.1363元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1432136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"广誉远(600771.SH)发布一季度业绩，归母净利润6674万元，同比增长4.96%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600771"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780657876676,"stockEarnings":[{"period":"1week","weight":0.0048},{"period":"1month","weight":-0.1169},{"period":"3month","weight":-0.1355},{"period":"6month","weight":-0.2227},{"period":"1year","weight":-0.3451},{"period":"ytd","weight":-0.1769}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0132},{"period":"3month","weight":-0.0161},{"period":"6month","weight":0.0397},{"period":"1year","weight":0.2019},{"period":"ytd","weight":0.0224}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广誉远中药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"65920人(较上一季度增加2.20%)","perCapita":"7425股","listingDate":"1996-11-05","address":"山西省晋中市太谷区广誉远路1号","registeredCapital":"48949万元","survey":" 广誉远中药股份有限公司的主营业务是中药产品的生产与销售。公司的主要产品是龟龄集、定坤丹大蜜丸、定坤丹水蜜丸、定坤丹口服液、安宫牛黄丸、牛黄清心丸、加味龟龄集酒、远字牌龟龄集酒。公司产品先后获得“山西精品”认定，六味地黄丸传统制作技艺及姜炭制作技艺入选晋中市非物质文化遗产名录。","listedPrice":4.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"广誉远(600771)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供广誉远(600771)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"广誉远,600771,广誉远股票,广誉远股票老虎,广誉远股票老虎国际,广誉远行情,广誉远股票行情,广誉远股价,广誉远股市,广誉远股票价格,广誉远股票交易,广誉远股票购买,广誉远股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"广誉远(600771)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供广誉远(600771)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}